CopyMark Law Group
4.9/5
Drawing for APEXBIO

USPTO serial 88590882

APEXBIO

Reviewed by CopyMark Law Group

Reg. 6081902Status 702Renewal
Filing date
Status date
Registration date
Jun 16, 2020
Examiner
GIPSOV, MARYNA K
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with APEXBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $850

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeannine Rittenhouse

Jeannine Rittenhouse IPHORGAN LTD.195 ARLINGTON HEIGHTS ROAD, SUITE 125BUFFALO GROVE, IL 60089United States

Goods and services

ClassDescriptionStatusFirst use
005Reagent strips for medical diagnostic use; glucose control solution for medical diagnostic use; uric acid control solution for medical diagnostic use; hemoglobin testing agents for medical diagnostic use; cholesterol testing agents for medical diagnostic use; lactic acid testing agents for medical diagnostic useACTIVEApr 3, 2020
010Testing and analytical apparatus for medical diagnostic use in the field of blood biochemistry; testing and analytical apparatus for medical diagnostic use in the field of urine biochemistry; blood uric monitoring apparatus for medical diagnostic use; blood glucose monitoring apparatus for medical use; lancets; hemoglobin testing apparatus for medical diagnostic use; cholesterol testing apparatus for medical diagnostic use; lactic acid testing apparatus for medical diagnostic useACTIVEApr 3, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 15, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 15, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 15, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 10, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Jun 16, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 16, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 15, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 14, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
May 12, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
May 11, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 27, 2020IUAFUSE AMENDMENT FILED—
Apr 27, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Apr 21, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 25, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 25, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 5, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 21, 2020ALIEASSIGNED TO LIE—
Jan 17, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 17, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Jan 17, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 17, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 17, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 2, 2019GPRNNOTIFICATION OF PRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 2, 2019GPRAPRIORITY ACTION E-MAILEDA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Dec 2, 2019CPRAPRIORITY ACTION WRITTENA priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline.
Nov 22, 2019DOCKASSIGNED TO EXAMINER—
Sep 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance